Skip to main content

Table 3 Patients and VAA characteristics according to the period of treatment

From: Visceral artery aneurysms: evolving interdisciplinary management and future role of the abdominal surgeon

N of patients Before 2013 Since 2013  
17 25  
Age median (range) 71 (47–91) 58 (30–80) P = 0.01
Female n (%) 6 (35%) 13 (52%) P = 0.29
Male n (%) 11 (65%) 12 (48%)  
Diameter in cm mean (SD) 2.9 (± 1.5) 2.6 (± 1.5) P = 0.52
Symptoms n (%) 11 (65%) 14 (41%) P = 0.57
 Abdominal pain n (%) 3 (18%) 5 (15%) P = 0.65
 Intraabdominal hemorrhage n (%) 8 (47%) 9 (26%)  
N of aneurysms 22 34  
 Splenic artery n (%) 5 (23%) 13 (38%) P = 0.76
 Hepatic artery n (%) 6 (27%) 7 (21%)  
 Superior mesenteric artery n (%) 5 (23%) 4 (12%)  
 Gastroduodenalis artery n (%) 3 (14%) 6 (18%)  
 Left gastric artery n (%) 2 (9%) 2 (6%)  
 Celiac trunk n (%) 1 (5%) 2 (6%)  
 N of true aneurysms 6 (27%) 26 (76%) P = 0.0006
 N of pseudoaneurysms 13 (59%) 8 (24%)  
 Indetermined morphology 3 (14%) 0 (0%)  
Operation n (%) 8 (47%) 3 (12%) P = 0.017
Intervention n (%) 9 (53%) 20 (80%)  
 Coiling n (%) 7 (41%) 16 (64%) P = 0.45
 Stenting n (%) 2 (12%) 2 (8%)  
 Stenting + coiling n (%) 0 (0%) 2 (8%)  
No operation/intervention n (%) 0 (0%) 2 (8%) P = 0.23
Emergency 8 (47%) 9 (36%) P = 0.62
Elective 9 (53%) 14 (56%)  
Complications n (%) 9 (53%) 8 (32%) P = 0.17
 Dindo 1 0 (0%) 2 (8%) P = 0.25
 Dindo 2 6 (35%) 2 (8%)  
 Dindo 3 2 (12%) 3 (12%)  
 Dindo 4 1 (6%) 1 (4%)  
Median hospital stay in days (range) 16 (1–238) 13 (2–122) P = 0.61
Median follow-up in months (range) 37 (0–151) 7 (0–46) P = 0.0007
N of deceased patients 2 (12%) 7 (28%) P = 0.21
  1. VAA visceral artery aneurysm, SD standard deviation
  2. Italic values indicate statistical significance (P<0.05)